Drug- and medtech developer Windtree Therapeutics (NSDQ:WINT) today said it appointed Diane Carman as senior VP and general counsel.
Carman will report directly to president and CEO Craig Fraser. She has more than two decades of experience working in life sciences and other highly regulated industries.
“We are delighted to welcome Diane to the Windtree team in her new role as general counsel,” Fraser said in a news release. “She is a talented and experienced executive with in-depth knowledge of pharmaceutical development companies and our clinical and business development operations. Her decades of legal and executive experience will be instrumental as we advance our multiple late-stage clinical candidates and grow the business.”
Prior to joining the company, Carman served as general counsel and secretary at Vitara Biomedical. She has also held numerous leadership roles at Helius Medical Technologies, Ablynx and Gamesa Technology.
“I am thrilled to join the very talented Windtree team at such a transformative time in the company’s growth. I look forward to helping advance the mission of the Company to develop innovative therapies intended to address significant unmet medical needs in important acute cardiovascular and pulmonary care markets,” Carman said.
